HealthDyne foresees rapid growth in its direct-to-employer business, 50,000 lives now and a million in the pipeline

Summary: HealthDyne is a pharmacy company that is growing very fast. They recently teamed up with the drug maker Eli Lilly to create a new program called Lilly Employer Direct. Instead of employees going to a regular pharmacy, their bosses can offer these medicines directly through the company's benefits.

Right now, 50,000 people get their medicine this way, but HealthDyne expects that number to hit 1 million soon. This program is especially popular for Eli Lilly's highly demanded weight-loss and diabetes drugs, Zepbound and Mounjaro. By cutting out the middleman, the price of Zepbound drops to $449. Plus, employers can chip in their own money to make the out-of-pocket cost even cheaper for their workers. It is a brand-new way to make expensive medicines much easier to afford.

For more details, see rssapp-managedhealthcareexecutive-com at managedhealthcareexecutive.com/view/healthdyne-foresees-rapid-growth-in-its-direct-to-employer-business-50-000-lives-now-and-a-million-in-the-pipeline-asembia-axs26-summit (opens in new tab)